![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 9 of 9. This is the beginning of the thread.
Posted by TriedEveryDrug on August 28, 2009, at 13:44:42
*First off, I'm not going to do anything stupid - these are just thoughts popping in my head.*
I've been taking pristiq for 6 or 7 weeks now (50mg)
I would rate it as a "meh". It has had little effect on my ADD (for which I'm trying)
I tried augmenting w/ 25mg of Strattera this morning.
I have these really annoying thoughts of suicide popping in my head now. I'm not going to act on them, no way, but it's irritating to say the least.
Does this go away?
Posted by Maxime on August 28, 2009, at 13:53:20
In reply to strattera and *thoughts* of sooey-cide?, posted by TriedEveryDrug on August 28, 2009, at 13:44:42
Do you think it's the pristiq that is causing the suicidal thoughts? It is possible. If that's the case you should probably talk to your doctor about it.
I hope you feel better soon.
Posted by TriedEveryDrug on August 28, 2009, at 13:58:10
In reply to Re: strattera and *thoughts* of sooey-cide?, posted by Maxime on August 28, 2009, at 13:53:20
No, it just started today when I added the strattera.
I had none of this with just the pristiq alone...I'm kind of afraid to even mention the S-word to my doctor. :-Z
Posted by SLS on August 28, 2009, at 14:35:39
In reply to Re: strattera and *thoughts* of sooey-cide? » Maxime, posted by TriedEveryDrug on August 28, 2009, at 13:58:10
Strattera usually fails as an antidepressant. It just works on the wrong part of the brain. Strattera really can work miracles for ADD, though.
Reboxetine, another NE reuptake inhibitor, turned my thoughts toward suicide within a few days of starting it. Suicidality was accompanied by anxiety.
- Scott
Posted by jrbecker76 on August 28, 2009, at 17:12:11
In reply to Re: strattera and *thoughts* of sooey-cide? » TriedEveryDrug, posted by SLS on August 28, 2009, at 14:35:39
>
> Reboxetine, another NE reuptake inhibitor, turned my thoughts toward suicide within a few days of starting it. Suicidality was accompanied by anxiety.
>
>
> - ScottOn Reboxetine and Milnacipran, it was not so much suicidal but being extremely despondent and emotionally unstable. I definitely feel that the noradrenergic component is at fault. I was also on Cymbalta during both of these drug trials as well. Although Cymbalta is a good antidepressant for me, it probably did make me more vulnerable to aforementioned effects of these other drugs, given the synergestic effects on NE.
JB
Posted by floatingbridge on August 28, 2009, at 22:11:11
In reply to strattera and *thoughts* of sooey-cide?, posted by TriedEveryDrug on August 28, 2009, at 13:44:42
Well, my pdoc mentioned strattera to me today to try as an anti-depressant and for add. Are you titrating upwards? Maybe thoughts will pass, but if they don't soon, I'm not sure it's worth it.
Is your ADD proving difficult to treat?
fb
Posted by sam K on August 28, 2009, at 23:03:59
In reply to strattera and *thoughts* of sooey-cide?, posted by TriedEveryDrug on August 28, 2009, at 13:44:42
maybe too much norepinephrine. if it keeps going add klonopin or something to regulate too much NE. just a theory
Posted by Phillipa on August 28, 2009, at 23:49:00
In reply to Re: strattera and *thoughts* of sooey-cide?, posted by sam K on August 28, 2009, at 23:03:59
I was under the impression that straterra was a weak med compared to say dexadrine or vyvanase. Phillipa
Posted by SLS on August 29, 2009, at 5:14:39
In reply to Re: strattera and *thoughts* of sooey-cide?, posted by Phillipa on August 28, 2009, at 23:49:00
> I was under the impression that straterra was a weak med compared to say dexadrine or vyvanase. Phillipa
It's just different. People can take both at the same time.
- Scott
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.